Carlsmed, Inc.
CARL
$9.83
$0.171.76%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 74.90% | 85.94% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.90% | 85.94% | -- | -- | -- |
| Cost of Revenue | 65.00% | 75.23% | -- | -- | -- |
| Gross Profit | 78.31% | 89.74% | -- | -- | -- |
| SG&A Expenses | 68.68% | 72.75% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 59.51% | 58.10% | -- | -- | -- |
| Operating Income | -39.24% | -26.75% | -- | -- | -- |
| Income Before Tax | -32.85% | -22.17% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -32.85% | -22.17% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.85% | -22.17% | -- | -- | -- |
| EBIT | -39.24% | -26.75% | -- | -- | -- |
| EBITDA | -38.68% | -26.34% | -- | -- | -- |
| EPS Basic | 59.36% | 39.93% | -- | -- | -- |
| Normalized Basic EPS | 57.43% | 40.75% | -- | -- | -- |
| EPS Diluted | 59.36% | 39.93% | -- | -- | -- |
| Normalized Diluted EPS | 57.43% | 40.75% | -- | -- | -- |
| Average Basic Shares Outstanding | 377.44% | 247.78% | -- | -- | -- |
| Average Diluted Shares Outstanding | 377.44% | 247.78% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |